Company Logo

Ustekinumab

Agricultural Biotechnology

Updated on May 7, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for Ustekinumab with ID of: 4209355
Recombinant monoclonal antibody to IL12+IL23. Ustekinumab (INN, experimental name CNTO 1275, proprietary commercial name Stelara, Centocor) is a human monoclonal antibody. It is directed against interleukin 12 and interleukin 23, naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.